v3.26.1
Segment Information
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
We manage our operations as a single reportable and operating segment for the purposes of assessing performance and making operating decisions. Our chief operating decision maker (“CODM”) is made up of our Chief Executive Officer and Chief Financial Officer. The CODM assesses performance and manages and allocates resources on a total company basis. Further, the CODM reviews and utilizes functional expenses at the consolidated level to manage our operations. The measure of segment assets is reported on the consolidated balance sheets as total assets.
The following table provides information about our single segment:

Three Months Ended March 31,
20262025
Operating Expenses:
   Significant components of research and development (R&D) expenses:
      Clinical trial expenses$747 $370 
      Manufacturing and related process development expenses507 414 
      Personnel-related expenses3,271 1,981 
   Significant components of general and administrative (G&A) expenses:
      Public company-related expenses3,016 1,200 
      Personnel-related expenses1,230 737 
      Intellectual property expenses302 107 
   All other R&D and G&A expenses208 212 
Total operating expenses9,281 5,021 
Loss from operations(9,281)(5,021)
Total other income, net38 310 
Net loss$(9,243)$(4,711)